Aperio Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$22.7M Buy
38,854
+431
+1% +$251K 0.07% 284
2020
Q3
$19.8M Buy
38,423
+4,278
+13% +$2.21M 0.07% 274
2020
Q2
$15.4M Buy
34,145
+5,152
+18% +$2.33M 0.06% 327
2020
Q1
$10.2M Buy
28,993
+8,798
+44% +$3.08M 0.04% 401
2019
Q4
$7.47M Buy
20,195
+405
+2% +$150K 0.03% 589
2019
Q3
$6.59M Buy
19,790
+630
+3% +$210K 0.03% 617
2019
Q2
$5.99M Sell
19,160
-2,142
-10% -$670K 0.02% 644
2019
Q1
$6.51M Sell
21,302
-26
-0.1% -$7.95K 0.03% 602
2018
Q4
$4.95M Buy
21,328
+2,388
+13% +$555K 0.03% 648
2018
Q3
$5.93M Sell
18,940
-16
-0.1% -$5.01K 0.03% 621
2018
Q2
$5.47M Sell
18,956
-171
-0.9% -$49.3K 0.03% 625
2018
Q1
$4.78M Buy
19,127
+235
+1% +$58.8K 0.02% 674
2017
Q4
$4.51M Sell
18,892
-551
-3% -$132K 0.02% 672
2017
Q3
$4.32M Buy
19,443
+254
+1% +$56.4K 0.02% 652
2017
Q2
$4.34M Buy
19,189
+1,976
+11% +$447K 0.03% 644
2017
Q1
$3.43M Buy
17,213
+2,470
+17% +$492K 0.02% 679
2016
Q4
$2.69M Sell
14,743
-3,096
-17% -$564K 0.02% 717
2016
Q3
$2.92M Buy
17,839
+4,309
+32% +$706K 0.02% 706
2016
Q2
$1.94M Buy
13,530
+4,901
+57% +$701K 0.02% 818
2016
Q1
$1.18M Buy
8,629
+783
+10% +$107K 0.01% 974
2015
Q4
$1.09M Buy
7,846
+2,684
+52% +$372K 0.01% 984
2015
Q3
$693K Buy
5,162
+549
+12% +$73.7K 0.01% 1134
2015
Q2
$695K Buy
4,613
+1,677
+57% +$253K 0.01% 1145
2015
Q1
$397K Buy
2,936
+635
+28% +$85.9K ﹤0.01% 1404
2014
Q4
$277K Sell
2,301
-145
-6% -$17.5K ﹤0.01% 1555
2014
Q3
$277K Buy
2,446
+210
+9% +$23.8K ﹤0.01% 1432
2014
Q2
$268K Buy
2,236
+167
+8% +$20K ﹤0.01% 1453
2014
Q1
$265K Buy
+2,069
New +$265K ﹤0.01% 1705
2013
Q4
Sell
-1,842
Closed -$217K 1651
2013
Q3
$217K Buy
+1,842
New +$217K ﹤0.01% 1602